These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 27275667)
1. Mesenchymal stem cell therapy promotes the improvement and recovery of renal function in a preclinical model. Urt-Filho A; Oliveira RJ; Hermeto LC; Pesarini JR; David Nd; Cantero Wde B; Falcão G; Marks G; Antoniolli-Silva AC Genet Mol Biol; 2016 Jun; 39(2):290-9. PubMed ID: 27275667 [TBL] [Abstract][Full Text] [Related]
2. Role of Bone Marrow Derived Mesenchymal Stem Cells and the Protective Effect of Silymarin in Cisplatin-Induced Acute Renal Failure in Rats. Ibrahim ME; Bana EE; El-Kerdasy HI Am J Med Sci; 2018 Jan; 355(1):76-83. PubMed ID: 29289267 [TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance imaging of mesenchymal stem cells transplanted intravascularly in treatment of acute renal failure:in vivo experiment with rats]. Sun JH; Teng GJ; Ma ZL; An YL; Mai XL; Ju SH; Yu H Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1921-4. PubMed ID: 19040008 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Herrera MB; Bussolati B; Bruno S; Fonsato V; Romanazzi GM; Camussi G Int J Mol Med; 2004 Dec; 14(6):1035-41. PubMed ID: 15547670 [TBL] [Abstract][Full Text] [Related]
5. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Lange C; Tögel F; Ittrich H; Clayton F; Nolte-Ernsting C; Zander AR; Westenfelder C Kidney Int; 2005 Oct; 68(4):1613-7. PubMed ID: 16164638 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Qian H; Yang H; Xu W; Yan Y; Chen Q; Zhu W; Cao H; Yin Q; Zhou H; Mao F; Chen Y Int J Mol Med; 2008 Sep; 22(3):325-32. PubMed ID: 18698491 [TBL] [Abstract][Full Text] [Related]
7. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785 [TBL] [Abstract][Full Text] [Related]
9. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Choi S; Park M; Kim J; Hwang S; Park S; Lee Y Stem Cells Dev; 2009 Apr; 18(3):521-9. PubMed ID: 18647091 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Semedo P; Wang PM; Andreucci TH; Cenedeze MA; Teixeira VP; Reis MA; Pacheco-Silva A; Câmara NO Transplant Proc; 2007 Mar; 39(2):421-3. PubMed ID: 17362746 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats. Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failure. Caldas HC; de Paula Couto TA; Fernandes IM; Baptista MA; Kawasaki-Oyama RS; Goloni-Bertollo EM; Braile DM; Abbud-Filho M Clin Exp Nephrol; 2015 Oct; 19(5):783-9. PubMed ID: 25630669 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury. Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980 [TBL] [Abstract][Full Text] [Related]
14. Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney. Behr L; Hekmati M; Fromont G; Borenstein N; Noel LH; Lelievre-Pegorier M; Laborde K Nephron Physiol; 2007; 107(3):p65-76. PubMed ID: 17940346 [TBL] [Abstract][Full Text] [Related]
16. Ameliorative effect of hepatocyte growth factor on glycerol-induced acute renal failure with acute tubular necrosis. Nagano T; Mori-Kudo I; Tsuchida A; Kawamura T; Taiji M; Noguchi H Nephron; 2002 Aug; 91(4):730-8. PubMed ID: 12138279 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of KW-3902, an adenosine A1-receptor antagonist, against cisplatin-induced acute renal failure in rats. Nagashima K; Kusaka H; Karasawa A Jpn J Pharmacol; 1995 Apr; 67(4):349-57. PubMed ID: 7650867 [TBL] [Abstract][Full Text] [Related]
18. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury. Guo Q; Wang J Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):168-172. PubMed ID: 29355065 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. Ding H; Kopple JD; Cohen A; Hirschberg R J Clin Invest; 1993 May; 91(5):2281-7. PubMed ID: 8486787 [TBL] [Abstract][Full Text] [Related]
20. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes. Altun B; Yilmaz R; Aki T; Akoglu H; Zeybek D; Piskinpasa S; Uckan D; Purali N; Korkusuz P; Turgan C Am J Nephrol; 2012; 35(6):531-9. PubMed ID: 22653289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]